ORIC Pharmaceuticals Inc (ORIC)

14.90 -0.21  -1.39% NASDAQ Oct 22, 16:00 15.00 +0.10  +0.67% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All ORIC News

News

View All Events

Events

Date Type Description
11/05/2021 Earnings Results Q3 2021 Earnings Results
08/10/2021 Earnings Results Q2 2021 Earnings Results
06/16/2021 11:00 EST AGM 2020 Annual General Meeting
05/06/2021 Earnings Results Q1 2021 Earnings Results
03/23/2021 Earnings Results Q4 2020 Earnings Results
11/05/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely, ORIC-101, ORIC-944, ORIC-114, and ORIC-533.
  • URL: https://oricpharma.com
  • Investor Relations URL: https://investors.oricpharma.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: N/A
  • Next Earnings Release: Nov. 05, 2021
  • Last Earnings Release: Aug. 10, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
F000018446 FT Top Picks June 2021 F CA 2.75%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.